Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience) - Guidance Document: Drug Submissions Relying on Third-Party Data (Literature and Market Experience)
There are no views created for this resource yet.
Additional Information
Created | August 30, 2023 |
---|---|
Format | HTML |